Literature DB >> 19888804

Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting.

L R Castañón Olivares1, K Martínez Martínez, R M Bermúdez Cruz, M A Martínez Rivera, W Meyer, R A Arreguín Espinosa, R López Martínez, G M Ruiz Palacios y Santos.   

Abstract

Cryptococcosis in México is caused by both species of the Cryptococcus species complex i.e., Cryptococcus neoformans and C. gattii. The current study was aimed to determine genetic variability of 72 Mexican clinical isolates using PCR-fingerprinting with the primer M13. PCR fingerprinting revealed 55 VNI, five VNII, three VNIII, one VNIV, two VGI, two VGII, two VGIII and two VGIV isolates among those studied. The results show that most cryptococcosis cases in México are AIDS related and are caused by C. neoformans var. grubii, genotypes VNI and VNII. In addition this study revealed for the first time the presence of genotypes VNIV and VGII among Mexican clinical isolates. The present data show that all genotypes that have been described for the Cryptococcus species complex are found in México, indicating a much wider geographic distribution of genotypes than previously reported. The molecular analysis of Mexican cryptococcal isolates generated PCR-fingerprinting patterns which will provide references for future typing studies to allow the integration of Mexican cryptococcal genotypes into the ongoing global genotyping study of the Cryptococcus species complex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888804     DOI: 10.3109/13693780802559031

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  24 in total

1.  Cryptococcus gattii pneumonia.

Authors:  Kerri A Johannson; Shaunna M Huston; Christopher H Mody; Warren Davidson
Journal:  CMAJ       Date:  2012-08-13       Impact factor: 8.262

2.  Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.

Authors:  Gloria M González; Néstor Casillas-Vega; Elvira Garza-González; Romel Hernández-Bello; Gildardo Rivera; Jesús Ancer Rodríguez; Virgilio Bocanegra-Garcia
Journal:  Folia Microbiol (Praha)       Date:  2015-06-25       Impact factor: 2.099

3.  Burden of serious fungal infections in Guatemala.

Authors:  N Medina; B Samayoa; D Lau-Bonilla; D W Denning; R Herrera; D Mercado; B Guzmán; J C Pérez; E Arathoon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-27       Impact factor: 3.267

Review 4.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues.

Authors:  Edmond J Byrnes; Kieren A Marr
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

6.  Cryptococcus gattii, no longer an accidental pathogen?

Authors:  Deborah J Springer; Sujal Phadke; Blake Billmyre; Joseph Heitman
Journal:  Curr Fungal Infect Rep       Date:  2012-12

7.  Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.

Authors:  Edmond J Byrnes; Wenjun Li; Yonathan Lewit; Hansong Ma; Kerstin Voelz; Ping Ren; Dee A Carter; Vishnu Chaturvedi; Robert J Bildfell; Robin C May; Joseph Heitman
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

8.  Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing.

Authors:  K R Klein; L Hall; S M Deml; J M Rysavy; S L Wohlfiel; N L Wengenack
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

9.  Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

Authors:  A Espinel-Ingroff; A I Aller; E Canton; L R Castañón-Olivares; A Chowdhary; S Cordoba; M Cuenca-Estrella; A Fothergill; J Fuller; N Govender; F Hagen; M T Illnait-Zaragozi; E Johnson; S Kidd; C Lass-Flörl; S R Lockhart; M A Martins; J F Meis; M S C Melhem; L Ostrosky-Zeichner; T Pelaez; M A Pfaller; W A Schell; G St-Germain; L Trilles; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

10.  Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010.

Authors:  Hsiang-Kuang Tseng; Chang-Pan Liu; Mao-Wang Ho; Po-Liang Lu; Hsiu-Jung Lo; Yu-Hui Lin; Wen-Long Cho; Yee-Chun Chen
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.